UBS upgraded MCX to Buy from Neutral and raised its target price to Rs 3,800, citing attractive valuations, resilient trading volumes and positive regulatory developments. The brokerage also raised its FY27-FY29 EPS estimates by 4%-9%, while expecting strong commodity volatility and operating leverage to support earnings growth.
Positive Breakout: These 12 midcap stocks cross above their 200 DMAs
In the NSE midcap pack, 13 stocks’ closing prices crossed above their 200-day moving averages (DMA) on September 18, 2026, according to StockEdge’s technical scan